LTRN Latest Quarter’s Earnings
Announce Date8/14/2026
EPS Actual (USD)-0.57
Revenue Actual (USD)--
Lantern Pharma Inc Earnings Dates & Reports
This page offers detailed Lantern Pharma Inc earnings data including the latest Lantern Pharma Inc earnings report, the upcoming Lantern Pharma Inc earnings date, historical data and Lantern Pharma Inc earnings call news.
LTRN Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
LTRN FY2025 Earnings
EPS (YoY)-1.5718.65%
Revenue (YoY)----
Lantern Pharma Inc (LTRN) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/14/2026 | 06/2026 | -0.57/-0.38 | --/0.00 | -49.81% | -- |
| 5/15/2026 | 03/2026 | -0.30/-0.36 | --/0.00 | 17.82% | -- |
| 3/30/2026 | 12/2025 | -0.36/-0.46 | --/0.00 | 20.84% | -- |
| 11/12/2025 | 09/2025 | -0.39/-0.47 | --/0.00 | 17.96% | -- |
| 8/13/2025 | 06/2025 | -0.40/-0.48 | --/0.00 | 17.20% | -- |
| 5/15/2025 | 03/2025 | -0.42/-0.49 | --/0.00 | 14.15% | -- |
| 3/27/2025 | 12/2024 | -0.54/-0.51 | --/0.00 | -6.82% | -- |
| 11/7/2024 | 09/2024 | -0.42/-0.56 | --/0.00 | 25.25% | -- |
Lantern Pharma Inc Latest Earnings Call Transcripts
Lantern Pharma (LTRN) Q2 2026 Earnings Call: Lower Operating Loss, LP-300 and Open Medicine AI
Lantern Pharma Q2 2026 earnings call: operating loss fell 25% to $3.5M, cash was $7.4M, while LP-300 and Open Medicine AI advanced.